Zhou, G.; Kan, X.; Zhang, F.; Ji, H.; Sun, J.; Yang, X.
Interventional Oncolytic Immunotherapy with LTX-315 for Residual Tumor after Incomplete Radiofrequency Ablation of Liver Cancer. Cancers 2022, 14, 6093.
https://doi.org/10.3390/cancers14246093
AMA Style
Zhou G, Kan X, Zhang F, Ji H, Sun J, Yang X.
Interventional Oncolytic Immunotherapy with LTX-315 for Residual Tumor after Incomplete Radiofrequency Ablation of Liver Cancer. Cancers. 2022; 14(24):6093.
https://doi.org/10.3390/cancers14246093
Chicago/Turabian Style
Zhou, Guanhui, Xuefeng Kan, Feng Zhang, Hongxiu Ji, Junhui Sun, and Xiaoming Yang.
2022. "Interventional Oncolytic Immunotherapy with LTX-315 for Residual Tumor after Incomplete Radiofrequency Ablation of Liver Cancer" Cancers 14, no. 24: 6093.
https://doi.org/10.3390/cancers14246093
APA Style
Zhou, G., Kan, X., Zhang, F., Ji, H., Sun, J., & Yang, X.
(2022). Interventional Oncolytic Immunotherapy with LTX-315 for Residual Tumor after Incomplete Radiofrequency Ablation of Liver Cancer. Cancers, 14(24), 6093.
https://doi.org/10.3390/cancers14246093